45963-555
Generic: gabapentin
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
gabapentin
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE
Active Ingredients
gabapentin 100 mg/1
Identifiers & Regulatory
Product NDC
45963-555
Product ID
45963-555_97b30b6f-8663-4025-b49a-ecbc01463fec
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2014-05-28
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
45963555
Hyphenated Format
45963-555
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: label)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA075350 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 5000 CAPSULE in 1 BOX (45963-555-00)
- 38675 CAPSULE in 1 CONTAINER (45963-555-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "97b30b6f-8663-4025-b49a-ecbc01463fec", "openfda": {}, "finished": false, "packaging": [{"description": "5000 CAPSULE in 1 BOX (45963-555-00)", "package_ndc": "45963-555-00", "marketing_start_date": "28-MAY-14"}, {"description": "38675 CAPSULE in 1 CONTAINER (45963-555-77)", "package_ndc": "45963-555-77", "marketing_start_date": "18-JAN-24"}], "product_id": "45963-555_97b30b6f-8663-4025-b49a-ecbc01463fec", "dosage_form": "CAPSULE", "product_ndc": "45963-555", "generic_name": "Gabapentin", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "GABAPENTIN", "strength": "100 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20140528", "listing_expiration_date": "20261231"}